• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

2 型糖尿病患者中的阻塞性睡眠呼吸暂停:全国初级保健数据库分析纳入了超重和肥胖人群,他们的风险增加。

Obstructive sleep apnoea in Type 2 diabetes mellitus: increased risk for overweight as well as obese people included in a national primary care database analysis.

机构信息

Department of Clinical and Experimental Medicine, University of Surrey, Guildford, UK.

出版信息

Diabet Med. 2019 Oct;36(10):1304-1311. doi: 10.1111/dme.13968. Epub 2019 May 6.

DOI:10.1111/dme.13968
PMID:31001841
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6767542/
Abstract

AIMS

To determine obstructive sleep apnoea prevalence in people with Type 2 or Type 1 diabetes in a national primary care setting, stratified by BMI category, and to explore the relationship between patient characteristics and obstructive sleep apnoea.

METHODS

Using the Royal College of General Practitioners Research and Surveillance Centre database, a cross-sectional analysis was conducted. Diabetes type was identified using a seven-step algorithm and was grouped by Type 2 diabetes, Type 1 diabetes and no diabetes. The clinical characteristics of these groups were analysed, BMI-stratified obstructive sleep apnoea prevalence rates were calculated, and a multilevel logistic regression analysis was completed on the Type 2 diabetes group.

RESULTS

Analysis of 1 275 461 adult records in the Royal College of General Practitioners Research and Surveillance Centre network showed that obstructive sleep apnoea was prevalent in 0.7%. In people with Type 2 diabetes, obstructive sleep apnoea prevalence increased with each increasing BMI category, from 0.5% in those of normal weight to 9.6% in those in the highest obesity class. By comparison, obstructive sleep apnoea prevalence rates for these BMI categories in Type 1 diabetes were 0.3% and 4.3%, and in those without diabetes 1.2% and 3.9%, respectively. Obstructive sleep apnoea was more prevalent in men than women in both diabetes types. When known risk factors were adjusted for, there were increased odds ratios for obstructive sleep apnoea in people with Type 2 diabetes in the overweight and higher BMI categories.

CONCLUSIONS

Obstructive sleep apnoea was reported in people with both types of diabetes across the range of overweight categories and not simply in the highest obesity class.

摘要

目的

在全国初级保健环境中,按 BMI 类别确定 2 型或 1 型糖尿病患者的阻塞性睡眠呼吸暂停患病率,并探讨患者特征与阻塞性睡眠呼吸暂停之间的关系。

方法

使用皇家全科医师学院研究和监测中心数据库进行横断面分析。使用七步算法确定糖尿病类型,并将其分为 2 型糖尿病、1 型糖尿病和无糖尿病。分析这些组的临床特征,计算 BMI 分层的阻塞性睡眠呼吸暂停患病率,并对 2 型糖尿病组进行多水平逻辑回归分析。

结果

对皇家全科医师学院研究和监测中心网络中 1275461 名成年患者记录的分析显示,阻塞性睡眠呼吸暂停的患病率为 0.7%。在 2 型糖尿病患者中,随着 BMI 类别逐渐增加,阻塞性睡眠呼吸暂停的患病率逐渐增加,从体重正常患者的 0.5%增加到最高肥胖组的 9.6%。相比之下,1 型糖尿病患者中这些 BMI 类别的阻塞性睡眠呼吸暂停患病率分别为 0.3%和 4.3%,无糖尿病患者分别为 1.2%和 3.9%。在两种类型的糖尿病中,阻塞性睡眠呼吸暂停在男性中比女性更为常见。在调整已知的危险因素后,超重和更高 BMI 类别的 2 型糖尿病患者发生阻塞性睡眠呼吸暂停的比值比增加。

结论

在超重类别的范围内,而不仅仅是在最高肥胖组中,报告了两种类型的糖尿病患者均有阻塞性睡眠呼吸暂停。

相似文献

1
Obstructive sleep apnoea in Type 2 diabetes mellitus: increased risk for overweight as well as obese people included in a national primary care database analysis.2 型糖尿病患者中的阻塞性睡眠呼吸暂停:全国初级保健数据库分析纳入了超重和肥胖人群,他们的风险增加。
Diabet Med. 2019 Oct;36(10):1304-1311. doi: 10.1111/dme.13968. Epub 2019 May 6.
2
At least one in three people with Type 2 diabetes mellitus referred to a diabetes centre has symptomatic obstructive sleep apnoea.在被转诊至糖尿病中心的2型糖尿病患者中,至少每三人就有一人患有症状性阻塞性睡眠呼吸暂停。
Diabet Med. 2014 Nov;31(11):1460-7. doi: 10.1111/dme.12477. Epub 2014 May 20.
3
Risk of incident obstructive sleep apnoea in patients with type 1 diabetes: a population-based retrospective cohort study.1 型糖尿病患者发生阻塞性睡眠呼吸暂停事件的风险:基于人群的回顾性队列研究。
Diabetologia. 2022 Aug;65(8):1353-1363. doi: 10.1007/s00125-022-05714-5. Epub 2022 May 24.
4
Obstructive sleep apnoea in people with Type 1 diabetes: prevalence and association with micro- and macrovascular complications.1型糖尿病患者的阻塞性睡眠呼吸暂停:患病率及其与微血管和大血管并发症的关联。
Diabet Med. 2015 Jan;32(1):90-6. doi: 10.1111/dme.12582. Epub 2014 Sep 25.
5
The relationship between obstructive sleep apnea and self-reported stroke or coronary heart disease in overweight and obese adults with type 2 diabetes mellitus.超重和肥胖 2 型糖尿病患者阻塞性睡眠呼吸暂停与自我报告的中风或冠心病之间的关系。
Sleep. 2012 Sep 1;35(9):1293-8. doi: 10.5665/sleep.2090.
6
Obstructive sleep apnea in normal weight patients: characteristics and comparison with overweight and obese patients.正常体重患者的阻塞性睡眠呼吸暂停:特征及与超重和肥胖患者的比较。
Arch Bronconeumol. 2013 Dec;49(12):513-7. doi: 10.1016/j.arbres.2013.05.005. Epub 2013 Jul 18.
7
Risk of Incident Obstructive Sleep Apnea Among Patients With Type 2 Diabetes.2 型糖尿病患者发生阻塞性睡眠呼吸暂停事件的风险。
Diabetes Care. 2019 May;42(5):954-963. doi: 10.2337/dc18-2004. Epub 2019 Mar 12.
8
Sleep architecture following a weight loss intervention in overweight and obese patients with obstructive sleep apnea and type 2 diabetes: relationship to apnea-hypopnea index.超重和肥胖的阻塞性睡眠呼吸暂停合并2型糖尿病患者体重减轻干预后的睡眠结构:与呼吸暂停低通气指数的关系
J Clin Sleep Med. 2014 Nov 15;10(11):1205-11. doi: 10.5664/jcsm.4202.
9
Quality of sleep and risk for obstructive sleep apnoea in ambulant individuals with type 2 diabetes mellitus at a tertiary referral hospital in Kenya: a cross-sectional, comparative study.肯尼亚一家三级转诊医院中2型糖尿病门诊患者的睡眠质量与阻塞性睡眠呼吸暂停风险:一项横断面比较研究。
BMC Endocr Disord. 2017 Feb 6;17(1):7. doi: 10.1186/s12902-017-0158-6.
10
Nocturnal hyperglycaemia in type 2 diabetes with sleep apnoea syndrome.2 型糖尿病伴睡眠呼吸暂停综合征患者的夜间高血糖。
Diabetes Res Clin Pract. 2011 Jan;91(1):e21-3. doi: 10.1016/j.diabres.2010.09.029.

引用本文的文献

1
Impact of body mass index on clinical outcomes in pediatric patients with mycoplasma pneumoniae pneumonia: a retrospective cohort study.体重指数对小儿支原体肺炎患者临床结局的影响:一项回顾性队列研究。
Transl Pediatr. 2025 Apr 30;14(4):608-617. doi: 10.21037/tp-2024-494. Epub 2025 Apr 27.
2
Association of self-reported sleep problems with morbidities and multimorbidities according to sex: National Health Survey 2019.根据性别报告的睡眠问题与患病和多种疾病的关联:2019 年全国健康调查。
Epidemiol Serv Saude. 2022;31(spe 1):e2021386. doi: 10.1590/SS2237-9622202200007.especial.
3
Changes in subjective sleep quality in patients with type 2 diabetes who did not use Sleep agents: a cross-sectional study according to age and clinical background.

本文引用的文献

1
Does Real World Use of Liraglutide Match its Use in the LEADER Cardiovascular Outcome Trial? Study Protocol.利拉鲁肽在现实世界中的使用与它在LEADER心血管结局试验中的使用相符吗?研究方案。
Diabetes Ther. 2018 Jun;9(3):1397-1402. doi: 10.1007/s13300-018-0390-8. Epub 2018 Mar 31.
2
8. Pharmacologic Approaches to Glycemic Treatment: .8. 血糖治疗的药物治疗方法: 。
Diabetes Care. 2018 Jan;41(Suppl 1):S73-S85. doi: 10.2337/dc18-S008.
3
Risk of Obstructive Sleep Apnea Assessment Among Patients With Type 2 Diabetes in Taif, Saudi Arabia.
未使用助眠药物的2型糖尿病患者主观睡眠质量的变化:一项根据年龄和临床背景的横断面研究。
Diabetol Int. 2021 Jun 2;13(1):142-147. doi: 10.1007/s13340-021-00516-3. eCollection 2022 Jan.
4
Comparing VA and Community-Based Care: Trends in Sleep Studies Following the Veterans Choice Act.比较退伍军人事务部医疗与社区医疗:《退伍军人选择法案》实施后的睡眠研究趋势
J Gen Intern Med. 2020 Sep;35(9):2593-2599. doi: 10.1007/s11606-020-05802-5. Epub 2020 Apr 2.
沙特阿拉伯塔伊夫2型糖尿病患者阻塞性睡眠呼吸暂停的风险评估
J Clin Med Res. 2017 Dec;9(12):1002-1006. doi: 10.14740/jocmr3189w. Epub 2017 Nov 6.
4
Prevalence and Associations of Obstructive Sleep Apnea in South Asians and White Europeans with Type 2 Diabetes: A Cross-Sectional Study.南亚和欧洲白种2型糖尿病患者阻塞性睡眠呼吸暂停的患病率及相关性:一项横断面研究
J Clin Sleep Med. 2017 Apr 15;13(4):583-589. doi: 10.5664/jcsm.6548.
5
Real-world evidence studies into treatment adherence, thresholds for intervention and disparities in treatment in people with type 2 diabetes in the UK.针对英国2型糖尿病患者的治疗依从性、干预阈值和治疗差异的真实世界证据研究。
BMJ Open. 2016 Nov 24;6(11):e012801. doi: 10.1136/bmjopen-2016-012801.
6
Sleep characteristics in type 1 diabetes and associations with glycemic control: systematic review and meta-analysis.1型糖尿病的睡眠特征及其与血糖控制的关联:系统评价与荟萃分析
Sleep Med. 2016 Jul;23:26-45. doi: 10.1016/j.sleep.2016.03.019. Epub 2016 Jun 8.
7
Royal College of General Practitioners Research and Surveillance Centre (RCGP RSC) sentinel network: a cohort profile.皇家全科医师学院研究与监测中心(RCGP RSC)哨点网络:队列概况。
BMJ Open. 2016 Apr 20;6(4):e011092. doi: 10.1136/bmjopen-2016-011092.
8
Effect of liraglutide 3.0 mg in individuals with obesity and moderate or severe obstructive sleep apnea: the SCALE Sleep Apnea randomized clinical trial.利拉鲁肽3.0毫克对肥胖合并中度或重度阻塞性睡眠呼吸暂停患者的影响:SCALE睡眠呼吸暂停随机临床试验
Int J Obes (Lond). 2016 Aug;40(8):1310-9. doi: 10.1038/ijo.2016.52. Epub 2016 Mar 23.
9
Insulin resistance, glucose intolerance and diabetes mellitus in obstructive sleep apnoea.阻塞性睡眠呼吸暂停中的胰岛素抵抗、葡萄糖不耐受和糖尿病
J Thorac Dis. 2015 Aug;7(8):1343-57. doi: 10.3978/j.issn.2072-1439.2015.08.11.
10
Cardiovascular autonomic neuropathy contributes to sleep apnea in young and lean type 1 diabetes mellitus patients.心血管自主神经病变会导致年轻且体型偏瘦的1型糖尿病患者出现睡眠呼吸暂停。
Front Endocrinol (Lausanne). 2014 Aug 11;5:119. doi: 10.3389/fendo.2014.00119. eCollection 2014.